Bioasis Technologies Inc.

bioasis technologies inc. is a ground-breaking biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier (bbb) and into the brain tissue. the delivery of therapeutics across the bbb represents the single greatest challenge in the treatment of over a thousand common and rare diseases of the central nervous system. fewer than 2% of medications are able to cross the bbb making this a large obstacle in patient treatment for brain diseases that affect 1 and 6 people worldwide. bioasis is seeking to address these unmet medical needs with its proprietary transcend platform. designed to transport therapeutics of varying types and sizes across the bbb, the transcend platform is based on receptor mediated transcytosis, nature's own method of carrying compounds into the brain. preclinical animal studies have shown that bioasis’ patented technologies (mtf & mtfp) are able to deliver a variety of compounds into to the brain for treatments in the areas of o